MarketInOut Stock Screener Log In | Sign Up

Haleos Labs Ltd

BSE • Healthcare • Biotechnology • Quote as of 10/27/2026 15:50
Haleos Labs Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeBSE
Market Capitalization4,709.98 mln
Float0.76 mln

EPS

54.26
Exceptional

P / E

27.51
Elevated

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.72
Likely reliable

Relative Strength

54 / 100
Slightly ahead

Debt / Equity

0.52
Moderate leverage

Business Description

Founded in 1990 and headquartered in Hyderabad, India, Haleos Labs Limited makes and sells active pharmaceutical ingredients and chemical intermediates used in a wide range of medicines. Its products support treatments for conditions including cancer, infections, high blood pressure, depression, and many others. The company sells both within India and to customers abroad, and was previously known as SMS Lifesciences India Limited before adopting its current name in August 2025.

Key Fundamentals

EPS54.26
P/E27.51
ROE7.69
RPS1,072
ROIC4.84
ROA3.73
Interest Cover3.86
EBITDA, mln440
EV / EBITDA12.94
EV / EBIT20.26
Revenue, mln3,242
EV / Revenue1.76

Quote Details

Last 1,492.70
Change 40.7 (2.8%)
Open 1,455.00
Volume 32
Turnover 47,766
Average Volume 98.57

Financial Ratios

Pre-Tax Profit Margin7
Leverage Ratio2.13
Current Ratio1.04
Price / Book1.94
Price / Tangible Book1.94
Price / Cash Flow15.09
Price / Free Cash Flow24.39
Debt / Equity0.52
Price / Sales1.37
PEG Ratio4.69

Financial Strength

Altman Z-Score2.39
Piotroski F-Score 4 / 9
Beneish M-Score-2.72
Price to Graham Number1.49
Shiller PE Ratio25.30

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.12% 60 / 100   
1 Month -2.53% 70 / 100   
2 Months 1.1% 71 / 100   
6 Months 13.54% 77 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog